Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis

US Patent 10738011 · Granted Aug 11, 2020

Estimated economic value: $1,175,000

Assignee

Inventors

View full patent text on Google Patents →